Synthesis and Biological Evaluation of Itraconazole Derivatives: Design in an Old Scaffold.

https://doi.org/10.1021/acs.inorgchem.5c02730

P300

RSC Med. Chem. 2025, 16, 3746–3763.

Pharmacophore-guided optimization of the hit compound CTN1122 in the design of promising imidazo[1,2-a]pyrazine derivatives targeting the casein kinase 1 for antileishmanial therapy

https://doi.org/10.1039/D5MD00257E

P290

ChemMedChem. 2025, 20, e202400862.

Investigating the C2 modulation of the imidazo[1,2-a]pyrazine-based hit compound CTN1122: synthesis, in vitro antileishmanial activity, cytotoxicity and casein kinase 1 inhibition.

https://doi.org/10.1002/cmdc.202400862

P196

ChemBioChem 2019, 20, 2255-2261.

Rapid synthesis and antiproliferative properties of polyazamacrocycle-based bi- and tetra-gold(I) phosphine dithiocarbamate complexes.

doi: 10.1002/cbic.201900227

P155

Anticancer Res. 2016, 36, 1621-1630.

Discovery of (imidazo[1,2-a]pyrazin-6-yl)ureas as antiproliferative agents targeting P53 in non-small cell lung cancer cell lines.

P154

Sci. Rep. 2016, 6, 21088;

Activation of EGFR by small compounds through coupling the generation of hydrogen peroxide to stable dimerization of Cu/Zn SOD1.

doi:10.1038/srep21088.

P138

Sci. Rep. 2015, 5:10356

TP53 transcription factor to NEDD9/HEF1/Cas-L gene: potential targets in Non Small Cell Lung Cancer treatment.

doi: 10.1038/srep10356

P121

Eur. J. Med. Chem., 2013, 69, 823-832.

Synthesis and antiproliferative activity of benzofuran-based analogs of cercosporamide against non-small cell lung cancer cell lines.

P111

J. Ocul. Pharmacol. Ther. 2012, 28, 299-306.

Study of antiproliferative effects of synthetic substances against lens epithelial cell line (SRA01/04).

P110

Gene, 2012, 506, 355-9.

miRNAs, a potential target in the treatment of Non-Small Cell Lung Carcinomas.